efe-epaBy Sarwar Kashani New Delhi

India on Monday authorized the use of hydroxychloroquine, a generic anti-malaria drug, for prevention of the novel coronavirus infection as the country grapples with the spread of the deadly disease that has claimed seven lives so far.

The authorization came as the government ordered a slew of measures, including a complete lockdown of 75 districts, to contain the disease in the densely inhabited country, which is the second-most populous in the world.